Loading...
Bromodomain and Extraterminal Protein Inhibitor, Apabetalone (RVX-208), Reduces ACE2 Expression and Attenuates SARS-Cov-2 Infection In Vitro
Effective therapeutics are urgently needed to counter infection and improve outcomes for patients suffering from COVID-19 and to combat this pandemic. Manipulation of epigenetic machinery to influence viral infectivity of host cells is a relatively unexplored area. The bromodomain and extraterminal...
Na minha lista:
| Udgivet i: | Biomedicines |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8072876/ https://ncbi.nlm.nih.gov/pubmed/33919584 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines9040437 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|